Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 494
Immune Disorders Drugs 208
Drug Discovery 169
Cardiovascular Drugs 165
Infectious Diseases Drugs 140
Biopharmaceuticals 131
Clinical Trials 128
Endocrine and Metabolic Disorders Drugs 113
Central Nervous System Drugs 107
Musculoskeletal Disorders Drugs 102
Pharmaceuticals 99
Hematological Drugs 85
Leukemia Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 57
Brain Cancer Drugs 50
Skin Cancer Drugs 50
Respiratory Drugs 45
Mental Disorders Drugs 44
Gastrointestinal Drugs 43
Lung Cancer Drugs 41
Drug Delivery 39
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 36
Pharmaceutical Manufacturing 33
Liver Cancer Drugs 30
Infusions and Injectables 30
Analgesics 27
Bladder Cancer Drugs 26
Antibiotics 26
Drugs by Therapeutic Area 25
Kidney Cancer Drugs 22
HIV/AIDS Drugs 21
Colon Cancer Drugs 20
Pancreatic Cancer Drugs 20
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Schizophrenia Drugs 17
Ovarian Cancer Drugs 16
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Breast Cancer Drugs 14
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Vaccines 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Alzheimer's Disease Drugs 8
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

2,539 Results (Page 60 of 127)
- Relevance
  Sort by

Castrate-resistant Prostate Cancer (CRPC) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€6985EUR$7,950USD£6,026GBP

Heart Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
35 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
151 Pages
Global

From

€3075EUR$3,500USD£2,653GBP

Bipolar Disorder Therapeutics Market 2024-2028

 Report
November 2023
161 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

AI in Clinical Trials Market (2nd Edition): AI Software and Service Providers - Distribution by Trial Phase, Target Therapeutic Area, End-user and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
July 2023
304 Pages
Global

From

€4217EUR$4,799USD£3,637GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Transdermal Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
150 Pages
Global

From

€3295EUR$3,750USD£2,842GBP

Molecular Diagnostics for Cancer: Market Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides

 Report
July 2025
448 Pages
Global

From

€6146EUR$6,995USD£5,302GBP

Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
45 Pages
Global

From

€3075EUR$3,500USD£2,653GBP

Bile Duct Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
June 2025
211 Pages
Global

From

€4389EUR$4,995USD£3,786GBP

Fungal Keratitis Treatment - Global Strategic Business Report

 Report
July 2025
484 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

High Potency APIs (HPAPIs) - Global Strategic Business Report

 Report
July 2025
192 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Sexually Transmitted Diseases (STD) Treatment Market 2024-2028

 Report
October 2024
145 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
580 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Hypertrophic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
87 Pages
Global

From

€1757EUR$2,000USD£1,516GBP

Leukemia Therapeutics Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3646EUR$4,150USD£3,145GBP

Hairy Cell Leukemia Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3646EUR$4,150USD£3,145GBP

T-Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

 Report
April 2025
182 Pages
Global

From

€3361EUR$3,825USD£2,899GBP

€3954EUR$4,500USD£3,411GBP

Mantle Cell Lymphoma Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Diffuse Large B-Cell Lymphoma Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Non Hodgkin Lymphoma (NHL) Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

2,539 Results (Page 60 of 127)
- 1
- 58
- 59
- 60
- 61
- 62

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.